Navigation Links
Reportlinker Adds World Market for Molecular Diagnostics: Potential and Reality, What's Hot and What's Not , The
Date:3/9/2011

NEW YORK, March 9, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

World Market for Molecular Diagnostics: Potential and Reality, What's Hot and What's Not, The

http://www.reportlinker.com/p0446069/World-Market-for-Molecular-Diagnostics-Potential-and-Reality-Whats-Hot-and-Whats-Not-The.html

There are many sanguine predictions made about the molecular diagnostics but to be useful, context is needed. How can companies sort out what is effective and what is not in this market? For over a decade, Kalorama Information's lead diagnostics analyst Shara Rosen, R.T., MBA has reviewed the molecular diagnostics market. A lot has changed, and a lot has stayed the same. There is intense competition but also opportunities for entrants in some areas. This report The World Market for Molecular Diagnostics: Potential and Reality, What's Hot and What's Not provides current market data for business planning but also goes beyond the numbers to fully assess what is going on in the market.

What are the important developments in the market? Who are the small innovators in this industry and how are the big players reacting to them? Which developments are "hot" - response from providers and payors and which trends have not caught on? In this report, Rosen provides answers to these questions.

The Rewards, Pitfalls and Competition of This High Potential MarketAs we enter the second decade of the 21st century the investment in molecular biology, in bioinformatics, in disease management research and the unraveling of the human genome is bearing fruit. Almost every day the discovery of new molecular markers for cancer, cardiac disease, diabetes, arthritis, neurological diseases and psychiatric conditions are announced.

This title, The World Market for Molecular Diagnostics -Potential and Reality, What's Hot and What's Not provides a detailed examination of molecular testing today. Among the data points the report provides are the following:

  • Current Market Size and Forecast for Molecular Segments (Infectious Disease, Blood Screening, Histology, Oncology, Prenatal, Coagulation, Tissue Typing, Inherited Diseases, Pharmacodiagnostics and Other)
  • Infectious Disease Molecular Sales by Disease (Hepatitis, HIV, GC/Chlamydia, HAI, Respiratory, Organism ID, Mycobacteria/TB, others)
  • Revenues of Top Molecular Diagnostic Companies
  • Recent Mergers and Acquisitions
  • Revenue of Test Service Companies
  • Geographic Breakout of Molecular Diagnostics Market by Region (North America, Europe, Asia, ROW)
  • Sample Prep Market, 2010 and 2015
  • Breakout of Molecular Histology/Cytology Market (in situ hybridization, HPV, Tissue Microarrays), 2010 and 2015
  • Important CLIA Lab Developments, 2008-2010

  • More and more laboratories offer complex panels of tests that help physicians evaluate disease risk and make therapeutic decisions. Government and private healthcare payors have recognized the value of new molecular tools and have agreed to pay for them.

    This renewed interest in IVDs in general and more particularly in molecular diagnostics has lead to the commercialization of a number of technological tools that make more sensitive and specific tests possible. Some of these technological innovations include: cost-effective, multiplexed testing platforms coupled with high-powered software capabilities. In addition analyses using saliva, urine, and blood instead of biopsied tissue make for more patient-friendly test systems.

    To order this report:: World Market for Molecular Diagnostics: Potential and Reality, What's Hot and What's Not, The

    More  Market Research Report

    Check our  Company Profile, SWOT and Revenue Analysis!CONTACT:  Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
    '/>"/>

    SOURCE Reportlinker
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Reportlinker Adds Three Alternative Scenarios of the Future In Vitro Diagnostics Market through 2018
    2. Reportlinker Adds The 2011 Clinical Chemistry and Immunodiagnostics Markets: US, Europe, Japan; Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
    3. Reportlinker Adds The 2011 Top Ten Worlds Leading Life Science Intermediates Companies
    4. Reportlinker Adds Biomarkers - Technologies, Markets and Companies
    5. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
    6. Reportlinker Adds RNAi - Technologies, Markets and Companies
    7. Reportlinker Adds Future Outlook for Common IT Platforms - Radiology and Cardiology
    8. Reportlinker Adds The 2011 Blood Banking Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers
    9. Reportlinker Adds Propylene Oxide: 2010 World Market Outlook and Forecast
    10. Reportlinker Adds Global Marine Biotechnology Industry
    11. Reportlinker Adds Global Biotechnology Reagents Industry
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/10/2016)... , ... February 10, 2016 , ... ... the International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st Annual Vendor ... expecting to fill more than 100 tables for its annual event, which will ...
    (Date:2/10/2016)... ... February 10, 2016 , ... PatientCrossroads announces ... the secure online PatientCrossroads platform, has exceeded both its one-year and overall recruitment ... PROMPT study, which seeks to advance understanding of the hereditary risks for certain ...
    (Date:2/10/2016)... ... February 10, 2016 , ... Cenna Bioscience Inc., an ... treatment of Alzheimer’s disease, announced today it has been selected to present at the ... Breakers in Palm Beach, Florida. The purpose of the Forum is to help ...
    (Date:2/9/2016)... 9, 2016  Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies ... organs, recently reported the Company,s operating results for ... 2016. Lonza America , Inc. (the ... year in the process of consummating an agreement ...
    Breaking Biology Technology:
    (Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
    (Date:2/1/2016)... -- Today, the first day of American Heart Month, the ... first of its kind workplace health solution that leverages ... first application of Watson to ... Welltok will create a new offering that combines AHA,s ... on Welltok,s health optimization platform. The effort is intended ...
    (Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the ... pharma and publication industries, will provide the data management ... Centre (NPSC). ... Phenotypic analysis measures ... whole organisms, allowing comparisons between states such as health ...
    Breaking Biology News(10 mins):